tirzepatide to retatrutide Switching from retatrutide: the complete transition guide What is the recommended protocol

On drug review platforms, tirzepatide (marketed as Mounjaro and Zepbound) carries an 8.7 out of 10 rating based on over 1,740 reviews, with 81% of users reporting positive experiences

It should look like water

Phase 2 trials investigated once-weekly subcutaneous doses of 1 mg to 12 mg with gradual escalation, but no regulatory authority has yet approved the medicine

US$22.37M company Lexaria Bioscience (NASDAQ:LEXX) is focused on making these therapies more tolerable and convenient for patients without reducing efficacy

This is in line with the fact that, although some studies have shown the presence of the GLP-1R in other parts of the heart ( Apart from the chronotropic effects, direct effects of GLP-1 specifically on the heart have not been comprehensively documented, although evidence exists to suggest that GLP-1 RAs may improve cardiac output as well as cardiomyocyte survival ( It should be noted that one of the two major DPP-IV-generated truncated forms of GLP-1 (GLP-1 [9-36amide]) has been shown to have direct beneficial cardiac effects in mice, which is representative of the hypothesis that a GLP-1R-associated response can be elicited also by these metabolites and thus not only via the classic incretin pathway ( Future perspectives In summary, the cardiovascular safety of all currently marketed GLP-1 RAs has been thoroughly established in large CVOTs ( As noted by others ( Of note, the finding of a markedly greater benefit on HF of efpeglenatide amongst trial participants using SGLT2 inhibitors at enrolment in the AMPLITUDE-O CVOT highlights another important point ( Another drug class widely used to treat type 2 diabetes is inhibitors of the enzyme dipeptidyl peptidase-4 (DPP4), which mediates enzymatic breakdown of GLP-1

However I just finished that one so Im going to be trying out this new Slimer one